CLINICAL UTILITY AND SAFETY OF NEW STRATEGY FOR PATIENTS WITH REFRACTORY KAWASAKI DISEASE: SINGLE INSTITUTION EXPERIENCE.

Subjects

Subjects :

*MUCOCUTANEOUS lymph node syndrome diagnosis
*MUCOCUTANEOUS lymph node syndrome
*PATIENT safety
*PLASMA exchange (Therapeutics)
*INFLIXIMAB
*BCG vaccines
*THERAPEUTICS

Details

Language :

English

ISSN :

07351097

Volume :

67

Issue :

13S

Database :

Academic Search Index

Journal :

Journal of the American College of Cardiology (JACC)

Publication Type :

Academic Journal

Accession number :

113724678

Full Text :

https://doi.org/10.1016/S0735-1097(16)32302-6